Professor Jonathan Van-Tam, Deputy Chief Medical Officer for England, has explained why new guidelines on the use of the Oxford AstraZeneca Covid-19 coronavirus vaccine have been issued.
It was announced that as a precaution, all under 40-year-olds would be offered an alternative to the Oxford / AstraZeneca Covid vaccine.
Professor Jonathan Van-Tam said it was important that the vaccine rollout continued at a good pace in order to control the coronavirus and minimize the impact of an increase in cases.
Speaking as new guidelines for the Oxford / AstraZeneca push were announced, he said the change shouldn’t detract from the goal of offering a first dose to all adults by the end of July.
During a television briefing that morning, he said, “The point has been stressed several times this morning to maintain the pace and volume of vaccine introduction in order to control the disease in our country in the long term and to minimize the impact of an upswing in cases that may connected to a third shaft.
“I can’t stress this enough. Additionally, I can tell you that, under current plans, our vaccine delivery plan will support the change offered by the JCVI (Joint Committee on Vaccination and Immunization) without limiting the speed and scope of vaccine adoption.
“I assume we are still aiming to offer a first dose to all adults by the end of July.”
When asked about the risk of vaccine reluctance in the face of the new AstraZeneca guidelines, Professor Jonathan Van-Tam told a briefing: “All the polls that I have read very clearly show that the UK public has a very, very high level of confidence in the vaccination program UK has already seen what it is doing to change our future and the data is getting better and stronger in terms of layers of protection, not just aversion to death, serious infections, but now preventing transmission for young adults too. “
He said younger people are “young and sociable” and “therefore they have a higher tendency to transference.”
He said continuing the vaccination program and maintaining confidence are “vital” not just in terms of a third wave but basically because although we are now in a very good epidemiological situation compared to even before a couple of months do not stay in control of this disease unless we continue to introduce the vaccination program. “